The three most widely followed indexes in the United States have ended the past trading week on a positive note. The Nasdaq ...

Quest Diagnostics (DGX) excels in diagnostics services but trades at a high valuation. Valuation analysis shows DGX trading ...

Quest Diagnostics (DGX) on Tuesday edged to a new record high, taking out the previous record high posted on March 10, 2025. ...

Quest Diagnostics Inc. closed 1.22% short of its 52-week high of $178.87, which the company achieved on March 10th.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Baird analyst Eric Coldwell maintained Quest Diagnostics with an Outperform rating and raised the price target from $191 to ...

Quest Diagnostics Inc.’s stock rose 3% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its full-year guidance, but acknowledged the early part of ...

Return on Equity (ROE): Quest Diagnostics's ROE is below industry standards, pointing towards difficulties in efficiently ...

Quest Diagnostics ( NYSE:DGX ) First Quarter 2025 Results Key Financial Results Revenue: US$2.65b (up 12% from 1Q... Quest Diagnostics Inc (DGX) reports a robust 12% revenue increase and reaffirms ...

The months-long strike at British Columbia’s LifeLabs has raised questions about foreign ownership of medical services and ...